2022
DOI: 10.1007/s00401-022-02425-4
|View full text |Cite
|
Sign up to set email alerts
|

Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
33
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(33 citation statements)
references
References 90 publications
0
33
0
Order By: Relevance
“…Similar conclusions have been recently published regarding αsynucleinopathies. The strain of the initial inoculum dictates the phenotype and pathology of seeding and spreading; however, the burden and spread of inclusion pathology throughout the neuraxis are also host-dependent [93].…”
Section: Discussionmentioning
confidence: 99%
“…Similar conclusions have been recently published regarding αsynucleinopathies. The strain of the initial inoculum dictates the phenotype and pathology of seeding and spreading; however, the burden and spread of inclusion pathology throughout the neuraxis are also host-dependent [93].…”
Section: Discussionmentioning
confidence: 99%
“…10 , A and B ). For transgenic mice expressing human A53T αS, termed TgM83 +/− , we previously reported that CNS PFF-injection resulted in widespread αS inclusion pathology throughout the neuroaxis, with the highest levels occurring in the hippocampus, hypothalamus, periaqueductal gray (PAG), midbrain and medulla ( 28 ). Comparatively, x-114 αS reactive inclusion pathology was present in the CNS of these mice but not extensively abundant in the hippocampus, cortex, amygdala, hypothalamus, thalamus, and spine, while moderately present in the midbrain, PAG, and medulla ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…This pathological spreading was contingent upon the presence of endogenous α-synuclein, since no α-synuclein-containing aggregates were observed when inoculations were made in α-synuclein null (Snca −/− ) mice [13,14]. Distinct histopathological and behavioral phenotypes were described as a result of injections of α-synuclein fibrils with different structural characteristics (so called α-synuclein "strains"), possibly mimicking the heterogeneous pathology that characterizes different human synucleinopathies [19][20][21]. Taken together, these observations strongly supported an intriguing mechanism of neuron-to-neuron transfer of α-synuclein lesions.…”
Section: Introductionmentioning
confidence: 99%